Glenmede Trust CO Na Immunity Bio, Inc. Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.67 - $10.18 $379,578 - $681,500	-66,945 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $1,283 - $1,993	140 Added 0.21%	66,945 $651,000
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $126,456 - $211,232	-9,430 Reduced 12.37%	66,805 $953,000
Q1 2021 May 18, 2021	BUY	$12.83 - $42.25 $978,095 - $3.22 Million	76,235 New	76,235 $1.81 Million

213

71.2M

1.64M

1.45M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.3B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.